Stanley Division of Developmental Neurovirology | Publications

Stanley Division of Developmental NeurovirologyStanley Division of Developmental NeurovirologyStanleylab.orgStanleylab.orgStanleylab.org

Stanleylab.org

People/StaffPublicationsPast Meetings & EventsDepartments/ProgramsFellowship ApplicationLaboratory Procedures


IN VITRO INHIBITION OF TOXOPLASMA GONDII BY FOUR NEW DERIVATIVES OF ARTEMISININ

Antimicrob Agents Chemother 50(12):4206-4208, 2006

Jones-Brando, L, D’Angelo J, Posner GH, Yolken R

Stanley Division of Developmental Neurovirology, Department of Pediatrics, Johns Hopkins University School of Medicine, 600 N. Wolfe St., Baltimore, MD 2128-4988, USA, [email protected]

ABSTRACT:

Toxoplasmosis, caused by the protozoan Toxoplasma gondii, is medically important and distributed worldwide. Currently available Medications are limited in terms of efficacy and side effects. We synthesized novel, nonacetal, hydrolytically stable derivatives of artemisinin and showed that they inhibit the replication of Toxoplasma gondii in cell culture.

 

Stanley Division of Developmental NeurovirologyJohn Hopkins Medicine

Home | People/Staff | Publications | Past Meetings & Events | Departments/Programs | Fellowship Application
Laboratory Procedures | About Us | Contact Us | Sitemap | Internal Use

©2005-2011 Stanley Division of Developmental Neurovirology

developed by Americaneagle.comAmericaneagle.com